Prevalence of Human Papillomavirus in Oropharyngeal Cancer: A Multicenter Study in Japan

Publisher： Karger

E-ISSN： 1423-0232|87|3|173-182

ISSN： 0030-2414

Source： Oncology, Vol.87, Iss.3, 2014-07, pp. : 173-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Staging and treatment of oropharyngeal cancer in the human papillomavirus era

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 7, 2015-07 ,pp. : 1002-1013

John Wiley & Sons Inc

Access to resources Recommend Favorite

What is the best treatment for patients with human papillomavirus–positive and –negative oropharyngeal cancer?

By  

CANCER, Vol. 120, Iss. 10, 2014-05 ,pp. : 1462-1470

John Wiley & Sons Inc

Access to resources Recommend Favorite

A cost‐effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer

By  

CANCER, Vol. 121, Iss. 11, 2015-06 ,pp. : 1785-1792

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus‐associated oropharyngeal squamous cell cancer

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 40, Iss. 2, 2018-02 ,pp. : 233-241

John Wiley & Sons Inc

Access to resources Recommend Favorite

Validation of the eighth edition American Joint Committee on Cancer staging system for human papillomavirus‐associated oropharyngeal cancer

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 40, Iss. 3, 2018-03 ,pp. : 457-466

John Wiley & Sons Inc

Access to resources Recommend Favorite